Paula Z. Proszek
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.
Journal: ESMO open
Published: March 24, 2026
Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling program.
Journal: NPJ precision oncology
Published: January 23, 2026
Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants.
Journal: British journal of haematology
Published: September 06, 2025
Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary Centre.
Journal: Current oncology (Toronto, Ont.)
Published: August 13, 2025
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia.
The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia.
Journal: Acta neuropathologica communications
Published: July 30, 2024
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.
Journal: Cancer discovery
Published: June 27, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 30, 2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 20, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.
Journal: Nature cancer
Published: September 13, 2023
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation.
Journal: The Journal of clinical investigation
Published: August 31, 2023
Last Updated: 09/26/2026